GAL, galanin and GMAP prepropeptide, 51083

N. diseases: 226; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C4225318
Disease: EPILEPSY, FAMILIAL TEMPORAL LOBE, 8
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8
0.600 Biomarker disease CTD_human
CUI: C0149958
Disease: Complex partial seizures
Complex partial seizures
0.100 Biomarker disease HPO
Complex partial seizure with impairment of consciousness
0.100 Biomarker disease HPO
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.060 AlteredExpression disease BEFREE Molecular cloning of cDNA encoding human galanin and galanin mRNA associated peptide (GMAP) from both pituitary and neuroblastoma sources has revealed a unique and unexpected structure. 1714839 1991
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.050 AlteredExpression disease BEFREE Molecular cloning of cDNA encoding human galanin and galanin mRNA associated peptide (GMAP) from both pituitary and neuroblastoma sources has revealed a unique and unexpected structure. 1714839 1991
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.050 AlteredExpression disease BEFREE Molecular cloning of cDNA encoding human galanin and galanin mRNA associated peptide (GMAP) from both pituitary and neuroblastoma sources has revealed a unique and unexpected structure. 1714839 1991
CUI: C0220656
Disease: Malignant ascites
Malignant ascites
0.010 Biomarker disease BEFREE To evaluate the ability of replication-deficient, recombinant adenovirus vectors to transfer genes to human tumor cells in vivo, adenovirus vectors containing the Escherichia coli lacZ (Ad.RSV beta gal) gene (coding for beta-galactosidase; used as a cell marker for gene transfer) or the human alpha 1-antitrypsin (Ad-alpha 1AT) cDNA (used as an example of a secreted protein) were administered intraperitoneally to nude mice with human malignant mesothelioma cell (H-MESO-1) malignant ascites. 7519451 1994
CUI: C0345967
Disease: Malignant mesothelioma
Malignant mesothelioma
0.010 Biomarker disease BEFREE To evaluate the ability of replication-deficient, recombinant adenovirus vectors to transfer genes to human tumor cells in vivo, adenovirus vectors containing the Escherichia coli lacZ (Ad.RSV beta gal) gene (coding for beta-galactosidase; used as a cell marker for gene transfer) or the human alpha 1-antitrypsin (Ad-alpha 1AT) cDNA (used as an example of a secreted protein) were administered intraperitoneally to nude mice with human malignant mesothelioma cell (H-MESO-1) malignant ascites. 7519451 1994
CUI: C0002395
Disease: Alzheimer's Disease
Alzheimer's Disease
0.080 Biomarker disease BEFREE Galanin (GAL) is a biologically active neuropeptide that has been suggested to play a role in stress-induced inhibition of insulin secretion, in dementia of the Alzheimer's type, and in the regulation of growth hormone secretion. 7520703 1994
CUI: C0027819
Disease: Neuroblastoma
Neuroblastoma
0.060 PosttranslationalModification disease BEFREE Primary sequence and functional analysis of the bovine galanin gene promoter in human neuroblastoma cells. 7520703 1994
CUI: C0700095
Disease: Central neuroblastoma
Central neuroblastoma
0.050 PosttranslationalModification disease BEFREE Primary sequence and functional analysis of the bovine galanin gene promoter in human neuroblastoma cells. 7520703 1994
CUI: C4086165
Disease: Childhood Neuroblastoma
Childhood Neuroblastoma
0.050 PosttranslationalModification disease BEFREE Primary sequence and functional analysis of the bovine galanin gene promoter in human neuroblastoma cells. 7520703 1994
CUI: C0016057
Disease: Fibrosarcoma
Fibrosarcoma
0.010 Biomarker disease BEFREE Using 8 cats with recurring 2.5-cm2 fibrosarcomas that either arose spontaneously or were induced by vaccine, we determined experimentally the administration routes and times required for optimum GAL-TEK gene transfer by beta-Gal histological staining and reverse transcriptase polymerase chain reaction to the multiple compartments of the growing fibrosarcomas consonant with minimizing collateral infection of neighboring tissues and other unwanted side effects. 8527480 1995
CUI: C0278595
Disease: Adult Fibrosarcoma
Adult Fibrosarcoma
0.010 Biomarker disease BEFREE GAL-TEK bifunctional marking and cell killing activities were tested in vitro after adenoviral vector infection of HT1080 human fibrosarcoma cells. 8527480 1995
CUI: C0007134
Disease: Renal Cell Carcinoma
Renal Cell Carcinoma
0.010 AlteredExpression disease BEFREE The pCMVbeta revealed the highest expression of the beta-gal gene in the renal cell carcinoma (RCC) lines. 9012452 1997
Conventional (Clear Cell) Renal Cell Carcinoma
0.010 AlteredExpression disease BEFREE The pCMVbeta revealed the highest expression of the beta-gal gene in the renal cell carcinoma (RCC) lines. 9012452 1997
CUI: C0271561
Disease: Somatotropin deficiency
Somatotropin deficiency
0.010 Biomarker disease BEFREE Two genes contained in this region, myelin basic protein, and the galanin receptor, are candidate genes for the growth hormone insufficiency phenotype. 9286448 1997
CUI: C0030193
Disease: Pain
Pain
0.070 Biomarker phenotype BEFREE Galanin is a neuroendocrine peptide that modulates many different normal physiological effects including memory, weight, and pain perception. 9425310 1997
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 GeneticVariation group BEFREE GALN is located at chromosome 11q13, a frequently amplified locus in diverse tumor types including breast cancer. 9537228 1998
CUI: C0006142
Disease: Malignant neoplasm of breast
Malignant neoplasm of breast
0.020 Biomarker disease BEFREE Thus, GALN amplification is unlikely to contribute to the phenotype conferred by 11q13 amplification in breast cancer, but preprogalanin mRNA is expressed by breast cancer cells and is under steroid hormone control in estrogen receptor-positive cells, opening the wider question of the role of this steroid-regulated neuropeptide in the normal and cancerous breast. 9537228 1998
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.020 Biomarker disease BEFREE Thus, GALN amplification is unlikely to contribute to the phenotype conferred by 11q13 amplification in breast cancer, but preprogalanin mRNA is expressed by breast cancer cells and is under steroid hormone control in estrogen receptor-positive cells, opening the wider question of the role of this steroid-regulated neuropeptide in the normal and cancerous breast. 9537228 1998
CUI: C1458155
Disease: Mammary Neoplasms
Mammary Neoplasms
0.010 Biomarker group BEFREE GALN was amplified in a subset of breast tumors and cell lines that carried 11q13 amplifications. 9537228 1998
CUI: C0017638
Disease: Glioma
Glioma
0.010 Biomarker disease BEFREE Replication-deficient adenovirus (Adv5)-based vectors containing either wild-type p53 or the beta-gal marker gene were introduced into cells of the T98G (p53 mutant) and U87MG (p53 wild-type) human glioma cell lines. 9650599 1998
CUI: C0158850
Disease: Fetal Malnutrition
Fetal Malnutrition
0.010 Biomarker disease BEFREE Incidentally, any defect in insulin secretion, whether in normoglycemic or hyperglycemic persons, could be due to other factors than primary beta-cell dysfunction: amyloid deposits in the pancreas (126), changes in insulin secretagogues (amylin, GLP-1, GIP, galanin) (127-130), early intrauterine malnutrition (131). 9715376 1998
Fetal malnutrition without mention of light-for-dates
0.010 Biomarker disease BEFREE Incidentally, any defect in insulin secretion, whether in normoglycemic or hyperglycemic persons, could be due to other factors than primary beta-cell dysfunction: amyloid deposits in the pancreas (126), changes in insulin secretagogues (amylin, GLP-1, GIP, galanin) (127-130), early intrauterine malnutrition (131). 9715376 1998